Profil
Sergio Quezada was the founder of Achilles Therapeutics UK Ltd. (2016) and Achilles Therapeutics Plc (2020) where the title held was Chief Scientific Officer (2020-2025).
Dr. Quezada's current job is at University College London as Professor-Cancer Institute (2011-present).
Education history includes undergraduate studies at Pontificia Universidad Católica de Chile and a doctorate from Dartmouth Medical School.
Aktive Positionen von Sergio Quezada
| Unternehmen | Position | Beginn |
|---|---|---|
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2011 |
Ehemalige bekannte Positionen von Sergio Quezada
| Unternehmen | Position | Ende |
|---|---|---|
| ACHILLES THERAPEUTICS PLC | Gründer | 01.02.2025 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Gründer | - |
Ausbildung von Sergio Quezada
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pontificia Universidad Católica de Chile
Pontificia Universidad Católica de Chile Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth Medical School
Dartmouth Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
Achilles Therapeutics Plc
Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
















